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Abstract
Background Most effective treatment for morbid obesity and its comorbidities is bariatric surgery. However, research is limited on
weight loss and associated outcomes among patients in Appalachia. The objective of this study was to examine demographic and
comorbidity influence on surgical outcomes of this population including age, sex, race, state of residence, education, marital status,
body mass index (BMI kg/m2), excess body weight (EBW), percent excess weight loss (%EWL), blood pressure, diagnosed
depression, diagnosed type 2 diabetes (T2D), Beck Depression Inventory-II (BDI-II), and laboratory values (i.e., hemoglobin A1c).
Methods A retrospective electronic medical record (EMR) data extraction was performed on N = 582 patients receiving bariatric
surgery (laparoscopic Roux-en-Y gastric bypass [RYGB] and laparoscopic sleeve gastrectomy [SG]) between 10/2013 and 2/2017.
Results Patient population was 92.5% Caucasian, 79.3% female, 62.8% married, 45 ± 11.1 years, 75.8% received RYGB, and
24.2% received SG. Average %EWL from baseline to 1-year follow-up was 68.5 ± 18.4% (n = 224). In final descriptive models,
surgery type, diagnosed T2D, HbA1c, and depressive symptoms were significant covariates associated with lower %EWL.
Conclusions Findings suggest patients completing surgery within an Appalachian region have successful surgical outcomes at 1-
year post-surgery, as indicated by significant reductions of > 50% EWL, regardless of other covariates. Results suggest that
bariatric programs should consider paying special consideration to patients with T2D or depressive symptoms to improve
outcomes. Results have potential to inform future prospective studies and aid in guiding specific interventions tailored to address
needs of this unique population.
Keywords Obesity . Bariatric surgery . Appalachia . Outcomes
Introduction
The Appalachian region has dramatic health disparities [1, 2]
reflected in the prevalence of type 2 diabetes (T2D), heart
disease, obesity, and mental illness in conjunction with eco-
nomic and infrastructure disparities [2–4]. The prevalence of
obesity within the Appalachian region is among the highest in
the world. Traditionally, obesity treatment has focused on be-
havioral, dietary, and lifestyle interventions that are employed
on a community-based level.
For individuals with class III obesity (BMI > 40 kg/m2),
which is over 6% of the US population, behavioral interven-
tions alone are often non-therapeutic, resulting in marginal
sustained weight loss and poor comorbidity resolution [5–8].
Metabolic and bariatric surgery has been proven to be the
most effective treatment for class II and III obesity and yet
remains highly underutilized [9–13]. Primary bariatric proce-
dures performed in the USA include laparoscopic Roux-en-Y
gastric bypass (RYGB) and laparoscopic sleeve gastrectomy
(SG) [9, 11, 14–16]. Between 2014 and 2017, total amount of
surgeries in the USA increased from 193,000 to 228,000 with
RYGB currently making up 17.8% and SG making up 59.4%
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[15, 16]. Of note, across the same years, RYGB surgeries have
declined (− 9.0%)while SG procedures increased (+ 7.7%) [15,
16]. Bariatric surgery results in a number of positive outcomes
such as significant reductions in excess body weight and de-
clines or remission of comorbidities (T2D, improved quality of
life, hypertension, gastrointestinal reflux disease, depression,
and others). As such, bariatric surgery represents the most ef-
fective treatment for individuals with morbid obesity [17–20].
However, in Appalachia, a region with high obesity preva-
lence and related health disparities, there is a gap in the re-
search regarding bariatric surgery patient populations and their
surgical and related outcomes. An article by Bergmann et al.
examined how the rural status of bariatric surgery patients
impacted their access to and outcomes of surgery [21]. This
study found that in patients having surgery, rural status (based
on Rural-Urban Commuting Areas) did not have a relationship
with surgical weight outcomes or compliance with follow-up
appointments at 1 year post-operatively. However, insurance
was a confounding factor in the study and often barred rural
individuals from obtaining surgery [21]. Additionally, Mock
et al. [22] examined limited food budgets among bariatric pa-
tients and found a significant reduction in weight loss out-
comes when on a limited budget at 3-month post-bariatric sur-
gery. However, that significance was not found at 12-month
post-bariatric surgery [22]. These studies highlight the impor-
tance of how variables such as baseline patient health and
demographics may influence outcomes. However, understand-
ing the impact of health disparities on the outcomes of
bariatric/metabolic surgery is also vital to mitigating the nu-
merous barriers faced by patients.
Thus, the objective of the current study is to expand the
knowledge base of bariatric surgery patients located in a
health disparate region of Appalachia. Specifically, the goal
of this study was to examine demographic, surgical/medical/
laboratory, weight outcomes from pre-surgery to 1-year post-
surgery and the influence baseline health measures had on
surgical outcomes. To our knowledge, this is the first study
to comprehensively describe a large Appalachian bariatric sur-
gery patient population and their surgical outcomes.
Materials and Methods
A retrospective chart review was performed of a high volume
bariatric surgical program in a tertiary university hospital that
provides care to the Appalachian population. Approval to con-
duct research was obtained via [Institution removed for
blinding purposes] Institutional Review Board (IRB Protocol
#1611355277). A patient query was completed on patients,
18 years and older, who had completed all required clearances
(i.e., cardiovascular, pulmonology, psychology) and received
RYGB or SG surgery between October 1st, 2013 and
December 31st, 2017. Formal consent was not required.
Patient surgeries at this clinic are > 99% funded through in-
surance. Retrieval of information was found in forms of both
electronically entered data as well as scanned and uploaded
PDF files. Uploaded PDF files included self-completed forms
from patient’s initial clinic visits (i.e., nutrition history, health,
and family history). All data were entered into a HIPAA com-
pliant RedCap survey and downloaded onto a secure, pass-
word protected, encrypted hard drive for further data analyses.
A second data pass was completed on 2% of charts to ensure
data reliability of 85%.
Study Measures
Patient electronic medical record (EMR) data were captured at
patients’ baseline clinic visit(s) for bariatric surgery with a
bariatric surgeon, dietician, nurse practitioner, physician’s as-
sistant, and psychologist. Baseline demographics, anthropo-
metrics, lab results (i.e., hemoglobin A1c), health history, fam-
ily history, nutrition habits, and psychological testing scores
(i.e., depression symptoms) were recorded at the time of these
visits. Changes in anthropometrics obtained through 1-year,
post-surgery, follow-up visits were logged in patients’ EMR.
The main outcome measure was percent excess weight loss
(%EWL) from baseline to 1-year follow-up with an ideal body
weight representing a BMI of 25 kg/m2. As used in other
studies, a %EWL of 50% or more achieved within 12 months
of surgery was considered a therapeutic success. Predictor
variables used include surgery type, age, gender, ethnicity,
education, marital status, percent follow-up attendance (num-
ber of follow-ups attended/determined by amount of follow-
ups possible multiplied by 100), diagnosed hypertension, di-
agnosed depression (defined as any ICD-10 depression diag-
nosis listed in patients’ charts as assigned by their providers),
and cooking responsibilities. HemoglobinA1c (HbA1c)
values, blood pressure values, and Beck Depression
Inventory II (BDI-II) scores were collected in addition to
physician-recorded diagnoses. These measures were also used
as predictor variables in separate models to examine ICD-10
diagnoses compared to other measurement forms to assess
blood glucose control, blood pressure, and self-reported de-
pressive measures.
Statistical Analyses
All analyses were performed using SAS (SAS®, Version 9.3)
[23] and JMP (JMP®, Version Pro 13) [24]. Data were exam-
ined for variable-specific outliers greater than 3 standard de-
viations above the mean, which were removed prior to analy-
ses (n = 10 outliers). Differences were tested between baseline
measures of surgery groups (RYGB vs. SG). An independent t
test was used for assessing association between %EWL and
variables with two groups (surgery type, gender, ethnicity,
education level, state, marital status, diagnosed T2D,
OBES SURG (2019) 29:1222–1228 1223
diagnosed hypertension, diagnosed depression). ANOVAwas
used for testing the hypothesis of equality among more than
two groups of categorical variables (education and marital
status), and Spearman’s Rho was used for examining correla-
tions of %EWL with continuous variables (age, % attended
follow-up, systolic blood pressure, diastolic blood pressure,
HbA1c, and BDI-II score). Fisher’s exact test was used for
cell sizes < 5. Significant correlations of p < 0.05 were includ-
ed in the next step of building ANOVA and ANCOVAmodels
to test relationships between %EWL and categorical and con-
tinuous predictor variables. ANOVA models tested ICD-10
diagnoses of diabetes, hypertension, and depression.
ANCOVA models tested HbA1c lab values, blood pressure
readings, and BDI-II scores as secondary measures. Model
assumptions of homoscedasticity, normality, and lack of
multicolinnearity were assessed. Cook’s D influence was set
at 0.0227 (4/n). Data with an influence greater than Cook’s D
were removed from analysis (n = 7). Effect size in models was
Table 1 Descriptive statistics, by
surgery type, of Appalachian
bariatric surgery patients between
2013 and 2017 receiving surgery
in West Virginia
Variable n Bypass n Sleeve p value
Demographics (n = 547)
Sex Male 407 81 (20) 128 29 (22.7) 0.5012
Female 326 (80) 99 (77.3)
State West Virginia 406 326 (80.3) 128 104 (81.3) 0.8121
Other 80 (19.7) 24 (18.7)
Race Caucasian only 407 376 (92.4) 127 118 (92.9) 1.0000
Other 31 (7.6) 9 (7.1)
Education High School or less 386 149 (38.6) 125 40 (32.0) 0.4079
Some College or Associates 131 (33.9) 44 (35.2)
Bachelors 67 (17.4) 29 (23.2)
Post Grad, Masters, PhD, Law 39 (10.1) 12 (9.6)
Marital Single 377 65 (17.2) 117 22 (18.8) 0.8468
Married 235 (62.3) 74 (63.2)
Divorced 53 (14.1) 16 (13.7)
Other 24 (6.4) 5 (4.3)
Diagnosed baseline comorbidities n % n %
T2D 138 37.3 36 30.0 0.1414
Hypertension 227 64.9 77 68.1 0.5226
Depression 184 53.0 67 59.8 0.2091
Baseline measures
Height (cm) 407 166.9 (9.4) 127 167.6 (9.4) 0.2308
Weight (kg) 407 136.5 (29.2) 127 139.5 (26.5) 0.1312
BMI (kg/m2) 407 48.5 (8.1) 127 49.4 (7.9) 0.2443
EBW (kg) 407 66.7 (25.3) 127 69.0 (23.8) 0.2344
HbA1c 195 6.1 (1.1) 64 6.1 (1.1) 0.6093
Systolic blood pressure 407 126.7 (13.7) 123 128.7 (13.7) 0.1053
Diastolic blood pressure 407 78.0 (8.3) 123 77.5 (7.8) 0.4733
Beck Depression Inventory 303 10.4 (9.0) 105 9.4 (105) 0.5659
Year 1 measures
Weight (kg) 188 90.5 (20.6) 36 103.2 (23.2) 0.0006*
BMI (kg/m2) 188 32.8 (5.9) 36 37.4 (7.6) 0.0004*
EBW (kg) 188 21.4 (17.0) 36 33.7 (21.0) 0.0003*
%EWL 188 71.8 (16.8) 36 51.1 (16.6) < 0.0001*
Independent t test was used for assessing association between %EWL and variables with two groups (surgery
type, gender, ethnicity, education level, state, marital status, diagnosed T2D, diagnosed hypertension, diagnosed
depression). ANOVAwas used testing for testing hypothesis of equality among more than two groups of cate-
gorical variables (education and marital status), and Spearman’s Rho was used for examining correlation of
%EWL with continuous variables (age, % attended follow-up, systolic blood pressure, diastolic blood pressure,
HbA1c, and BDI). Fisher’s exact test used for cell sizes < 5
*Significant at < 0.05 level
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assessed by change in adjusted R2 values to calculate variance
of each variable when placed in the model. ANOVA models
were computed using PROCMIXED procedure Type III Sum
of Squares (SS) in SAS (partial), and ANCOVA models were
computed using PROC GLM procedure Type I SS (sequen-
tial). In partial SS, the hypothesis to be tested are invariant to
the ordering of effects in the model. In sequential SS, order of
effects matters, and latter effects are being adjusted to previous
variable effects in the model. For example, effect of surgery
type on%EWL is adjusted to HbA1c on%EWL. Effect size in
final models was assessed by change in adjusted R2 values to
calculate variance of each variable when placed in the model.
Stepwise modeling was used for ANOVA and ANCOVA tests
to allow results of each variable to be shown through their
individual extent of influence in relationship to %EWL.
Further, utilizing both categorical indicators of diagnosed di-
abetes and depression as well as continuous indicators to re-
move caution of differences among outcomes when using
categorical or continuous variables.
Results
From the initial query, data was captured on a total of 582
patient charts. Sample size was based on time and data limi-
tations. Thirty-five charts and corresponding data were re-
moved due to type of surgery being a gastric band or revision
of previous surgery leaving a sample of n = 547. The bariatric
surgery patients were predominately 92.5% Caucasian, 79.3%
female, 62.8%married, 45 ± 11.1 years old, and 75.8% receiv-
ing RYGB surgery. When stratifying the population by sur-
gery type, similar demographic breakdowns were seen. No
significant demographic differences were found between two
surgery type groups (Table 1). RYGB patients had an average
baseline weight of 136.5 ± 29.2 kg, BMI of 48.5 ± 8.1 kg/m2,
and EBWof 66.7 ± 25.3 kg. SG patients had average baseline
weight of 139.5 ± 26.5 kg, BMI of 49.2 ± 8.0 kg/m2, and
EBW of 69.0 ± 23.8 kg. The EMR was examined for the fol-
lowing reported baseline comorbidities: diagnosed T2D (n =
174), diagnosed depression (n = 259), and diagnosed hyper-
tension (n = 304). Among these comorbidities, no significant
differences were found among groups at baseline (Table 1; all
p > 0.05). Likewise, no significant differences between sur-
gery groups were found among objective measures of
HbA1c, blood pressure, and BDI scores (all p values >
0.05). Percent follow-up at 1-year appointment was 47% for
bypass (n = 196) and 30% for sleeve patients (n = 40)
(p < 0.001). Average %EWL among whole sample was
68.80 ± 18.92% with bypass patients achieving higher
%EWL than their sleeve counterparts (p < 0.0001).
Bivariate analyses identified 6 of 15 dependent variables of
interest that had significant associations (p < 0.05) with
%EWL (Table 2). Surgery type, age, diagnosed T2D,
diagnosed depression, diagnosed hypertension, and HbA1c
values all found to have a significant association with
%EWL (Table 2; all p < 0.05). As HbA1c and diagnosed
T2D were both significantly related to %EWL, separate
models were used to display their effect as they both describe
abnormal glucose control. Variables were utilized in further
model building to test the influence of each significant identi-
fied variable on predicting %EWL at 1-year post-bariatric sur-
gery. In a preliminary full screening model, surgery type, di-
agnosed T2D, depression, and hypertension, and HbA1c value
remained significant (Table 2). To further analyze variance of
%EWL caused by remaining significant variables ANOVA
and ANCOVA models were built (Tables 3 and 4; Figs. 1–5).
Both HbA1c and Diagnosed T2D measured blood glucose
control status and thus, separate models were designed for both
Model 1: %EWL= surgery type
Model 2: %EWL= surgery type + diagnosed T2D
Model 3: %EWL= surgery type + HbA1c
Model 4: %EWL= surgery type + diagnosed T2D + diag-
nosed depression
Model 5: %EWL = surgery type + HbA1c + diagnosed
depression
Table 2 Values between percent excess weight loss and other possible
associated variables for entry into ANOVA and ANCOVA models
Success variable Covariates Test effect p value
%EWL
Categorical Surgery type − 6.900 < 0.0001**
Gender 1.274 0.2070
Ethnicity 0.397 0.6973
Education level 0.455 0.7141
State − 0.106 0.9160
Marital Status 1.966 0.1202
Diagnosed T2D − 4.015 < 0.0001**
Diagnosed hypertension − 2.235 0.0274*
Diagnosed depression − 2.913 0.0040**
Continuous Age − 0.258 < 0.0001**
% attended follow-up − 0.520 0.4375
Systolic blood pressure − 0.752 0.2625
Diastolic blood pressure − 0.012 0.8545
HbA1c − 0.313 0.0002**
BDI − 0.005 0.9469
Independent t test was used for assessing association between%EWL and
variables with two groups (surgery type, gender, ethnicity, education lev-
el, state, marital status, T2D, diagnosed hypertension, diagnosed depres-
sion). ANOVAwas used testing for testing hypothesis of equality among
more than two groups of categorical variables (education and marital
status), and Spearman’s Rho was used for examining correlation of
%EWL with continuous variables (age, % attended follow-up, systolic
blood pressure, diastolic blood pressure, HbA1c, and BDI).
*Significant at < 0.05 level
**Significant at < 0.01 level
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Model 1 examines the main effect of surgery alone on
%EWL (F (1,222) = 45.72, p < 0.0001). Figure 1 shows sig-
nificantly higher %EWL in bypass patients (72.16 ± 17.44
%EWL) compared to sleeve (51.15 ± 16.62 %EWL) at 1-
year follow-up (p < 0.001). Effect of diagnosed T2D, surgery,
and interaction between T2D and surgery on %EWL is
depicted in model 2. Type 3 fixed effects for both surgery (F
(1,199) = 44.95, p < 0.0001) and EMR-diagnosed T2D were
significant (F (1,199) = 15.49, p = 0.0001). Fig. 2 represents
the main effect of surgery type although interaction between
the two were not significant (F (1,199) = 0.38, p = 0.5368).
Model 3 examines surgery type, EMR-diagnosed T2D, and
EMR-diagnosed depression and their interactions. Type 3
fixed effects identify significance among surgery type (F
(1,170) = 15.88, p < 0.0001), diagnosed T2D (F (1,170) =
5.59, p = 0.0192), as well as diagnosed depression (F
(1,170) = 8.37, p = 0.0043). All interaction terms between
each combination of surgery, T2D, and depression were found
as non-significant (p > 0.05).
Among models 4 and 5 (Table 4), diagnosed T2D was
replaced with objective measure of HbA1c blood glucose con-
trol. Model 4 (F (3,133) = 9.46, p < 0.0001), examined main
effect of surgery on %EWL while controlling for HbA1c.
Model 4 had an R-squared value of 0.31 and found both sur-
gery type and HbA1c had significant relationship with%EWL
(p’s < .0001); however, interaction term between surgery and
HbA1c was not significant (p = 0.07). Model 5 (F (7, 110) =
9.46, p < 0.0001) with an R-squared value of 0.39, examined
main effect of surgery type on %EWL while controlling for
HbA1c and diagnosed depression. Variables of surgery type
(p < 0.0001), HbA1c (p < 0.0001), and diagnosed depression
(p = 0.0229) were all significant; however, all interaction com-
binations were not statistically significant (p > 0.05).
Discussion
In this sample of Appalachian RYGB and SG patients, 1-year
weight loss outcomes were comparable to and exceeded those
in the current literature. Various studies and reviews identify
bariatric surgery as aiding in the success of 40–71% EWL
post-surgery [14].Within each ANOVA and ANCOVAmodel
in this study, SG patients typically had less %EWL than
RYGB patients. Additionally, we found a trend that patients
with a diagnosis of T2D or depression, according to ICD-10
codes, achieved lower %EWL. We were able to identify that
each variable separately (surgery type, diagnosed T2D, elevat-
ed HbA1c, and diagnosed depression) impacts %EWL.
Generally, those receiving SG, being diagnosed with T2D or
depression, or having a higher HbA1c at baseline had lower
%EWL at 1-year post-op. Our data is consistent with previous
data. Specifically, in patients with T2D receiving SG, patients
had a 47% EWL which is similar to our findings [25]. The
well-known Swedish Obese Subject (SOS) study examined
Table 3 Models and Figs. 1–3: ANOVA model building and figures of surgery, T2D, and depression relationship with %EWL outcome
Model 1 (n=224) Model 2 (n=203) Model 3 (n=178)
Variable Df F p Df F p Df F p
Surgery Type 1 45.72 <.0001** 1 44.95 <.0001** 1 15.88 0.0001**
Diag. T2D - - - 1 15.49 0.0001** 1 5.59 0.0192*
Surgery*Diag T2D - - - 1 0.38 0.5368 1 0.17 0.6781
Diag. Depression - - - - - - 1 8.37 0.0043**
Surgery*Depress - - - - - - 1 3.68 0.0566
Diag Diab*Depress - - - - - - 1 3.68 0.1707
Surg*Diab*Depres - - - - - - 1 2.86 0.0927
Residuals 282.52 - - 266.09 - - 234.43 - -
Adj R2 0.17 0.25 0.31
F-Value 45.72 23.58 12.38
Figure 1 Figure 2 Figure 3
Model building throughANOVA analyses examining main effect of surgery type (model 1; Fig. 1). Model 2 and Fig. 2 depict main effect of surgery type
with diagnosed T2D as well as the interaction term. Model 3 and Fig. 3 includes variables of model 2 with the additional effect of diagnosed depression
and interaction terms between surgery type, T2D, and depression
*Significance level of < 0.05
**Significance level of < 0.01
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longitudinal weight among surgical patients [20, 26, 27].
However, a limitation of the SOS is that no SG procedures
were performed. In a 2003–2015 registry reported by the
International Federation for Surgery for Obesity and
Metabolic Disorders, 49.4% received RYGB followed by
40.7% receiving SG [28]. Total body weight loss at 1-year
follow-up in this registry population was 30% [28]. A similar
study by Shah et al. examined retrospective data of bypass and
sleeve patients. Outcomes of > 50% EWL were seen more
frequently in those patients who had lower initial BMI, ab-
sence of T2D, and underwent RYGB surgery [29]. Our pop-
ulation data shows similar results as compared to these listed
studies and national averages for percent excess body weight
loss 1 year after surgery. With this study being the first to our
knowledge to examine an Appalachian centered population,
more work is warranted to determine whether these results can
be replicated in other rural regions and settings.
Due to the retrospective nature of data retrieval, some data
could not be captured through the patient EMR. For example,
forms that were hand-written and scanned into the chart were,
at times, illegible, which led to incomplete data. Further, our
patient population was primarily Caucasian females who re-
ceived RYGB. Of these patients, a significantly higher amount
of bypass patients returned for 1-year follow-up as compared to
SG patients. Due to this outcome, caution needs to be taken
with results based on lack of follow-up in SG, generalizability
to a larger study population attention should be taken. Had a
larger percentage of SG returned for follow-up appointments,
outcomes may have reflected differently. However, overall, this
population demographic is largely representative and similar to
that of the nation’s bariatric surgery demographic breakdown.
In summary, this study found that although patients may
reside in a health disparate location such as Appalachia, bar-
iatric and metabolic surgeries can still be successful for
achieving significant weight loss after 1-year follow-up.
Specifically, results indicate when utilizing SG for weight loss
surgery in this geographical region, successful outcomes may
be less frequent when patients have additional comorbidities.
However, overall consideration needs to be taken when
supporting individuals with obesity related comorbidities such
as T2D and depression because those factors were associated
with lower %EWL. Therefore, it is recommended that health
practitioners/public health experts endorse metabolic surgery
for populations who are morbidly obese, specifically in
Appalachian regions, as well as support individuals with co-
morbidities with additional resources for success, particularly
among SG. However, due to limited longitudinal data regard-
ing this population, future research examining success of
Table 4 Models and Figs. 4 and 5: ANCOVA model building and figures of surgery, HbA1c, and depression relationship with %EWL outcome
Model 4 (n=134) Model 5 (n=111)
Variable Df SS F value p Df SS F value p
Model 3 13248 19.76 <.0001** 7 13672 9.46 <.0001**
HbA1c 1 4285.1 19.17 <.0001** 1 3691.3 17.88 <.0001**
Surgery Type 1 8231.3 36.83 <.0001** 1 7960.8 38.56 <.0001**
Surgery Type*HbA1c 1 732.0 3.28 0.0726 1 732.0 3.55 0.0625
Diagnosed Depression - - - - 1 1102.1 5.34 0.0229*
Surgery Type*Diagnosed Depression - - - - 1 111.2 0.54 0.4647
HbA1c*Diagnosed Depression - - - - 1 28.5 0.14 0.7108
Surgery*HbA1c*Depression - - - - 1 46.2 0.22 0.6372
Error 130 29053 - - 103 21263 - -
Corrected Total 133 42301 - - 110 34935 - -
Adj R2 0.30 0.35
F-Value 19.76 9.46
Figure 4 Figure 5
In sequential SS, order of effects matters and latter effects are being adjusted to previous variable effects in the model. For examples, effect of surgery
type on%EWL is adjusted to HbA1c on %EWL.Model 4 and Fig. 4 depict main effect of surgery type with covariate HbA1c (Hemoglobin A1c) values
as well as their interaction.Model 5 and Fig. 5 includes covariates of model 4 with the additional covariate effect of diagnosed depression and interaction
terms between surgery type, HbA1c, and depression
*Significance level of < 0.05
**Significance level of < 0.0
OBES SURG (2019) 29:1222–1228 1227
behavioral and dietary patterns as well as comorbidity resolu-
tion are warranted.
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